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Purpose: We aimed to analyze survival rates and dura-
tion of cancer patients who treated with Traditional Korean
Medicine (TKM).
Methods: We analyzed the medical records of 971 patients
who were treated more than 1 month of out-patient or 20 days
of hospitalization at the Daejeon Oriental Hospital from Oct.
2004 to Sep. 2014. The survival rates andmedian survival dura-
tion (MSD) were estimated by the Kaplan-Meier method and
Log-rank test. Seven different kinds of cancers patients who
were suffered from liver, thyroid, colon & rectum, stomach,
breast, pancreas, or lung cancer were analyzed by gender, age,
and cancer stage-speciﬁc. We also estimated survival rates
and MSD of 203 terminally ill cancer patients.
Results: The 5-year survival rates and MSD of 971 patients
was 38.6% (95%CI 34.8 – 42.3), 3.28-year (95%CI 2.87 - 3.65)
respectively. The 5-year survival rates of liver, colon & rec-
tum, stomach, breast, pancreas and lung cancer patients were
30.0% (95% CI 19.5 – 40.5), 25.0%(95% CI 16.0 – 34.0), 24.4%(95%
CI 16.2 – 32.6), 79.3%(95% CI 70.4 – 88.1), 3.4% (95% CI 0.0 –
9.3), 22.2%(95% CI 12.6 – 31.8), respectively. The MSD for liver,
colon & rectum, stomach, breast, pancreas and lung cancer
patients was 2.27-year (95%CI 1.21 - 3.50), 3.11-years (95%CI
2.67 - 3.58), 1.96-year (95%CI 1.71 - 2.52), 8.04-year (95%CI 7.01
- 10.69), 1.01-year (95% CI 0.80 - 1.21), 2.07-years (95%CI 1.47 -
2.53), respectively. Moreover, the MSD of terminally ill cancer
patients was 0.39-years (about 20 weeks, 95%CI 0.33 - 0.44) and
0.5-year survival rates for them were 40.7% (95%CI 33.6 - 47.7),
respectively.
Conclusion: All cancer types were not obviously extended
the survival duration by treatment with TKM, the survival
rate, especially for the liver, breast, pancreas and lung can-
cer patients are relatively higher than other treatment.
Well-designed and prospective clinical trials should be rec-
ommended to provide more reliable evidence.
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Purpose: The objective of this study is to assess the pain-
relief efﬁcacy of percutaneous radiofrequency (RF) stimulation
on acupuncture points (APs) in the treatment of patients suf-
fering from low back pain (LBP) as a preliminary study.
Methods: A total of 56 LBP patients whose minimum pain
intensity on visual analogue scale (VAS, 0-100mm) was more
than 30mm were randomly allocated to either control or
treatment group. The treatment group (n=28) receivedRF stim-
ulation on four bilateral and three unilateral APs for three
times a week. The placebo-controlled group (n=28) received
false stimulation on the identical APs with the treatment
group.All patients after randomizationwere required to report
the case report format baseline, all of three times of treatment
periods and the follow-up period within 7 days after all treat-
ments. The primary outcome was the change of VAS scores
from baseline to the end of the follow-up period.
Results: The patient’s reported change of VAS scores
between baseline and the follow-up period (average: 9.8 days)
were signiﬁcantly decreased by 8.0± 13.0mm (90% conﬁdence
interval: -12.2 to -3.9, p<0.01) in the treatment group, and
13.4± 14.3mm (90% conﬁdence interval: -18.0 to -8.8, p<0.001)
in the placebo-controlled group. The difference between the
treatment groupand theplacebo-controlled groupwas 5.4mm
(90% conﬁdence interval: -11.4 to 0.7, p=0.145).
Conclusion:Our preliminary results indicate that therewas
signiﬁcant change inVAS scores for lowpack pain between the
baseline and the follow-upperiodwithinbothgroups,whereas
there was no signiﬁcant difference between the groups. A
future clinical trial shall be designedwith the long termperiod
andacive control to verify the efﬁcacyof acupoints stimulation
with RF.
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